Paper32320003
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
Richardson S and 27 others. JAMA, 2020. Cited by 6,489 papers, by iCite.
Cite this record
ConductScience Library. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. Papers, record 32320003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32320003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
- PubMed
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Betacoronavirus | Major topic |
| Comorbidity | Major topic |
| Coronavirus Infections | Major topic |
| Pneumonia, Viral | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| COVID-19 | |
| Child | |
| Child, Preschool | |
| Diabetes Complications | |
| Female | |
| Hospitalization | |
| Humans | |
| Hypertension | |
| Infant | |
| Infant, Newborn | |
| Male | |
| Middle Aged | |
| New York City | |
| Pandemics | |
| Risk Factors | |
| SARS-CoV-2 | |
| Treatment Outcome | |
| Young Adult |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K23 HL145114 | NHLBI NIH HHS | United States | K23HL145114 | PubMed and NIH | NIH RePORTER |
| R01 LM012836 | NLM NIH HHS | United States | R01LM012836 | PubMed and NIH | NIH RePORTER |
| R24 AG064191 | NIA NIH HHS | United States | R24AG064191 | PubMed and NIH | NIH RePORTER |
Trials19
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT04407260 | Use of Oxygen Hoods in Patients Failing on Conventional High-flow Oxygen Delivery Systems, Effects on Oxygenation in Hypoxic COVID-19 Patients. Prospective Cohort Study. | Background | ClinicalTrials.gov | |
| NCT04411459 | Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome | Results | ClinicalTrials.gov | |
| NCT04414059 | Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients | Background | ClinicalTrials.gov | |
| NCT04442789 | Sequelae of Sars-CoV-2 Infections | Background | ClinicalTrials.gov | |
| NCT04454372 | Clinical Characteristics and Outcomes of 187 Critically Ill Patients With Coronavirus Disease 2019 (COVID-19) | Results | ClinicalTrials.gov | |
| NCT04482621 | Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial | Background | ClinicalTrials.gov | |
| NCT04516811 | Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19 | Background | ClinicalTrials.gov | |
| NCT04534803 | BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST) | Background | ClinicalTrials.gov | |
| NCT04623138 | A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections | Background | ClinicalTrials.gov | |
| NCT04689711 | Prognostic Models for COVID-19 Care | Background | ClinicalTrials.gov | |
| NCT04704544 | Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE) | Background | ClinicalTrials.gov | |
| NCT04757272 | Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019? | Background | ClinicalTrials.gov | |
| NCT04865029 | Estradiol and Progesterone in Hospitalized COVID-19 Patients | Background | ClinicalTrials.gov | |
| NCT04884776 | Modulation of Gut Microbiota to Enhance Health and Immunity | Background | ClinicalTrials.gov | |
| NCT04894617 | Amantadine for COVID-19 | Background | ClinicalTrials.gov | |
| NCT05036824 | Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients | Background | ClinicalTrials.gov | |
| NCT05087290 | LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR) | Background | ClinicalTrials.gov | |
| NCT05108896 | Aspiration in Acute Respiratory Failure Survivors 2 | Background | ClinicalTrials.gov | |
| NCT05950230 | Periodontal Health in Post COVID-19 Patients | Background | ClinicalTrials.gov |
Comments and corrections4
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Erratum in | 32330939 | Clarification of Mortality Rate and Data in Abstract, Results, and Table 2. | https://conductscience.org/library/papers/32330939 | PubMed |
| Comment in | 32693957 | Increased mortality among hypertensive COVID-19 patients: Pay a closer look on diuretics in mechanically ventilated patients. | https://conductscience.org/library/papers/32693957 | PubMed |
| Comment in | 33944543 | Covid-19: less bronchial airways, more lung alveolar space and blood ways. | https://conductscience.org/library/papers/33944543 | PubMed |
| Comment in | 34111330 | Are ventilators part of the problem or the solution for COVID-19 mortality? | https://conductscience.org/library/papers/34111330 | PubMed |
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32171076 | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. | Lancet | 2020 | https://conductscience.org/library/papers/32171076 | PubMed |
| 2 | 32191259 | Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. | JAMA | 2020 | https://conductscience.org/library/papers/32191259 | PubMed |
| 3 | 32233753 | Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? | J Am Heart Assoc | 2020 | https://conductscience.org/library/papers/32233753 | PubMed |
| 4 | 3558716 | A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. | J Chronic Dis | 1987 | https://conductscience.org/library/papers/3558716 | PubMed |
| 5 | 32004427 | First Case of 2019 Novel Coronavirus in the United States. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32004427 | PubMed |
| 6 | 15897343 | Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. | Circulation | 2005 | https://conductscience.org/library/papers/15897343 | PubMed |
| 7 | 26466050 | Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies. | Lancet | 2015 | https://conductscience.org/library/papers/26466050 | PubMed |
| 8 | 32148129 | Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005-2016. | Hypertension | 2020 | https://conductscience.org/library/papers/32148129 | PubMed |
Cited by5,226
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6,489 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42930509 | Clinical Outcomes and Hospital Resource Utilization Among Patients with Sepsis and COVID-19 Infection: Insights from the United States National Inpatient Sample Analysis, 2020-2022. | Infect Dis Rep | 2026 | https://conductscience.org/library/papers/42930509 | PubMed |
| 42928916 | The Value of the White Blood Cell-to-Hemoglobin Ratio in Acute Lower Respiratory Tract Infections of Pseudomonas Aeruginosa. | Infect Drug Resist | 2026 | https://conductscience.org/library/papers/42928916 | PubMed |
| 42924406 | Post-COVID-19 Clinic Utilization Among Survivors of Critical Illness in Two Waves of SARS-CoV-2 Infection. | CHEST Crit Care | 2024 | https://conductscience.org/library/papers/42924406 | PubMed |
| 42903821 | Innate immune response in COVID-19 pneumonia during the pandemic: a prospective cohort study. | Ann Intensive Care | 2026 | https://conductscience.org/library/papers/42903821 | PubMed |
| 42890005 | Comparative Analysis of Clinical, Laboratory, and Imaging Profiles in Tuberculosis Patients Pre- and Post-COVID-19 Pandemic. | Tanaffos | 2025 | https://conductscience.org/library/papers/42890005 | PubMed |
| 42846240 | Investigating Why Clinicians Deviate from Standards of Care: Liberating Patients from Mechanical Ventilation in the ICU. | Proc SIGCHI Conf Hum Factor Comput Syst | 2024 | https://conductscience.org/library/papers/42846240 | PubMed |
| 42777573 | Noninvasive ventilation use and ICU mortality in COVID-19-related acute respiratory failure: a retrospective cohort study. | Clinics (Sao Paulo) | 2026 | https://conductscience.org/library/papers/42777573 | PubMed |
| 42654375 | Admission Laboratory-Based Prediction of Six-Month Mortality After COVID-19 Hospitalization: Model Development, Bootstrap Internal Validation, and Single-Center Temporal Validation. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42654375 | PubMed |
| 42555810 | Implementation of an Emergency Medical Service-Integrated Teleconsultation Follow-Up Unit for Home-Based Patients With Suspected COVID-19 During Epidemiological Uncertainty in an Island Territory: Retrospective Descriptive Study. | JMIR Form Res | 2026 | https://conductscience.org/library/papers/42555810 | PubMed |
| 42506648 | Six Years of COVID-19: Lessons from Epidemiology, Vaccination Campaigns, Clinical Risk Stratification, and Thromboembolic Surveillance. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42506648 | PubMed |
| 42485657 | Mortality Risks by Occupation During the Early Wave of the COVID-19 Pandemic in New York City. | Am J Ind Med | 2026 | https://conductscience.org/library/papers/42485657 | PubMed |
| 42460028 | Effect of Remdesivir on Mortality in Mechanically Ventilated COVID-19 Patients: A Target Trial Emulation Using Inverse Probability of Treatment Weighting. | Infect Drug Resist | 2026 | https://conductscience.org/library/papers/42460028 | PubMed |
| 42416744 | Clinical Profile and Severity Spectrum of COVID-19 Patients with and without Comorbidities Admitted to a Tertiary Care Hospital in India. | Maedica (Bucur) | 2026 | https://conductscience.org/library/papers/42416744 | PubMed |
| 42375209 | Critical shortage of gastrointestinal physician density in the USA: impact on mortality from upper gastrointestinal bleeding. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42375209 | PubMed |
| 42368561 | VPS34 inhibition as a host-targeting anti-coronaviral strategy: Rational design of YBM with optimized pharmacokinetic parameters. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42368561 | PubMed |
| 42358431 | Development of remote radar based vital sign acquisition for emergency department patient triage. | Front Med Technol | 2026 | https://conductscience.org/library/papers/42358431 | PubMed |
| 42317324 | Immunogenetic modulation of endothelial inflammation by the LIPG -384A/C promoter variant influences COVID-19 severity. | Front Immunol | 2026 | https://conductscience.org/library/papers/42317324 | PubMed |
| 42272879 | Letter to the Editor: Chest X-ray-based severity scores in COVID-19 - what do they tell us about oxygen needs? | World J Crit Care Med | 2026 | https://conductscience.org/library/papers/42272879 | PubMed |
| 42272756 | Development of a machine learning-based mortality prediction model for patients with mental disorders and COVID-19. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42272756 | PubMed |
| 42232044 | Comparison of clinical characteristics and outcomes between COVID-19 survivors and non-survivors: a retrospective observational study. | Wellcome Open Res | 2024 | https://conductscience.org/library/papers/42232044 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32320003
GET https://conductscience.org/api/papers/v1/32320003/authors?page=2